Skip to main content

. 1984 Dec 8;289(6458):1580–1581. doi: 10.1136/bmj.289.6458.1580

Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system.

G Williams, D Kerle, S Griffin, H Dunlop, S R Bloom

PMCID: PMC1443905 PMID: 6239674

1580

Images in this article

p1581-a
on p.1581

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Kerle D., Williams G., Ware H., Bloom S. R. Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone. Br Med J (Clin Res Ed) 1984 Aug 25;289(6443):468–469. doi: 10.1136/bmj.289.6443.468. [DOI] [PMC free article] [PubMed] [Google Scholar]
Post E. M., Richman R. A., Blackett P. R., Duncan K. P., Miller K. Desmopressin response of enuretic children. Effects of age and frequency of enuresis. Am J Dis Child. 1983 Oct;137(10):962–963. doi: 10.1001/archpedi.1983.02140360026009. [DOI] [PubMed] [Google Scholar]
Williams G., Allen J. M., O'Shea J. P., Mashiter K., Doble A., Bloom S. R. Prostatic cancer: treatment with long-acting LHRH analogue. Br J Urol. 1983 Dec;55(6):743–746. doi: 10.1111/j.1464-410x.1983.tb03417.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES